TARDBP Protein, Human (His)

1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

TARDBP protein is an RNA-binding factor with RRM1 and RRM2 that binds GU repeats and regulates RNA splicing in long introns and 3'UTRs.It affects proteins critical for neuronal survival and neurodegenerative diseases.TARDBP Protein, Human (His) is the recombinant human-derived TARDBP protein, expressed by E. coli , with N-6*His labeled tag.

For research use only. We do not sell to patients.
  • Species: Human
  • Source: E. coli
  • Storage:
    Stored at -80°C for 1 year from date of receipt. It is stable at -20°C for 3 months after opening. It is recommended to freeze aliquots at -80°C for extended storage. Avoid repeated freeze-thaw cycles.
  • Biological Activity
  • Technical Parameters
  • Product Properties
  • Documentation
  • Help & FAQs

Biological Activity

Description

TARDBP protein is an RNA-binding factor with RRM1 and RRM2 that binds GU repeats and regulates RNA splicing in long introns and 3'UTRs.It affects proteins critical for neuronal survival and neurodegenerative diseases.TARDBP Protein, Human (His) is the recombinant human-derived TARDBP protein, expressed by E. coli , with N-6*His labeled tag.

Background

The TARDBP protein, an RNA-binding factor, plays a multifaceted role in various steps of RNA biogenesis and processing. Utilizing its two RNA recognition motifs, RRM1 and RRM2, TARDBP preferentially binds GU-repeats on RNA molecules, predominantly localized within long introns and the 3'UTR of mRNAs. This binding activity regulates the splicing of numerous non-coding and protein-coding RNAs, impacting proteins crucial for neuronal survival and those relevant to neurodegenerative diseases. TARDBP also contributes to mitochondrial homeostasis by regulating the processing of mitochondrial transcripts and modulates mRNA stability by recruiting CNOT7/CAF1 deadenylase to mRNA 3'UTR, leading to poly(A) tail deadenylation. In response to oxidative insult, TARDBP associates with stalled ribosomes in stress granules, contributing to cell survival. Moreover, it participates in skeletal muscle formation and regeneration by forming cytoplasmic myo-granules and binding mRNAs encoding sarcomeric proteins. Additionally, TARDBP is involved in the maintenance of circadian clock periodicity by stabilizing CRY1 and CRY2 proteins in a FBXL3-dependent manner and negatively regulates the expression of CDK6. Interactions with various proteins, including BRDT, ATXN2, MATR3, UBQLN2, HNRNPA2B1, ZNF106, CNOT7/CAF1, CRY2, and PPIA/CYPA, highlight the diverse roles of TARDBP in RNA regulation and cellular processes.

Verified Bioactivity

Measured by its binding ability in a functional ELISA.Immobilized Human TARDBP, His Tag at 1 μg/mL (100 μL/well) can bind Anti-TARDBP Antibody with a linear range of 0.2-3 ng/mL.

MCE Validation Data

  • Purity - SDS-PAGE

    Purity - SDS-PAGE

    ≥ 90%, as determined by reducing SDS-PAGE.

  • Bioactivity - ELISA

    Bioactivity - ELISA

    Measured by its binding ability in a functional ELISA.Immobilized Human TARDBP, His Tag at 1 μg/mL (100 μL/well) can bind Anti-TARDBP Antibody. The ED50 for this effect is 2.113 ng/mL.

Technical Parameters

  • Species Human
  • Source E. coli
  • Tag N-10*His
  • Accession
  • Gene ID
  • Molecular Construction
    • N-term
    • His
    • TARDBP (M1-M414)
      Accession # Q13148-1
    • C-term
  • Protein Length

    Full Length

  • Synonyms

    TARDBP; TDP43; TAR DNA Binding Protein; TAR DNA Binding Protein, Isoform CRA_c; TDP-43; TAR DNA-Binding Protein-43; TAR DNA-Binding Protein 43; TDP43 Isoform F; ALS10

  • AA Sequence

    MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDLKEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNSKQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNAEPKHNSNRQLERSGRFGGNPGGFGNQGGFGNSRGGGAGLGNNQGSNMGGGMNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGPSGNNQNQGNMQREPNQAFGSGNNSYSGSNSGAAIGWGSASNAGSGSGFNGGFGSSMDSKSSGWGM

  • Predicted Molecular Mass

    46.8 kDa

  • Molecular Weight

    Approximately 54-56 kDa, based on SDS-PAGE under reducing conditions.

  • Purity

    ≥ 90%, as determined by reducing SDS-PAGE.

Product Properties

Appearance

Solution

Formulation

Supplied as a 0.22 μm filtered solution of 50 mM HEPES, 500 mM NaCl, 0.4 M Arginine, pH 8.0 with 20% glycerol as protectant.

Endotoxin Level

<1 EU/μg, determined by LAL method.

Storage & Stability

Stored at -80°C for 1 year from date of receipt. It is stable at -20°C for 3 months after opening. It is recommended to freeze aliquots at -80°C for extended storage. Avoid repeated freeze-thaw cycles.

Shipping

Shipping with dry ice.

Calculators

Reconstitution Calculator

Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration

Volume (to add to vial) Volume (to add to vial)
=
Mass (in vial) Mass (in vial)
÷
Desired Reconstitution Concentration Desired Reconstitution Concentration
Dilution Calculator

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

Concentration (start) Concentration (start)
×
Volume (start) Volume (start)
=
Concentration (final) Concentration (final)
×
Volume (final) Volume (final)
The Specific Activity Calculator Equation
  • Specific Activity (Unit/mg)
  • Biological Activity (ED50)

Specific Activity (Unit/mg) = 106 ÷ Biological Activity (ED50)

Specific Activity (Unit/mg) Specific Activity (Unit/mg)
Unit/mg
= 106 ÷
Biological Activity (ED50) Biological Activity (ED50)
106 ÷
ng/mL
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00